[Treatment of patients with hemophilia A having antibodies to factor VIII]

Acta Haematol Pol. 1979 Apr-Jun;10(2):115-22.
[Article in Polish]

Abstract

Four haemophiliacs with antibodies to factor VIII were treated on 7 occasions with fraction FEIBA. Satisfactory clinical results were achieved in patients receiving large doses of the preparation (63-105 units/kg). The administration of fraction FEIBA produced shortening of the whole blood clotting time but there was only a slight correction in the activated partial thromboplastin time. Two patients received prothrombin complex concentrate without clinical improvement in 1 case a good haemostatic effect was achieved after the infusion of cryoprecipitate and in 1 postoperative bleeding ceased with the administration of porcine factor VIII Immunosuppressive therapy with cyclophosphamide in 3 patients failed to prevent the anamnestic rise in antibody titer.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies* / analysis
  • Cryoprotective Agents / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Factor IX / therapeutic use*
  • Factor VIII / immunology*
  • Hemophilia A / therapy*
  • Humans
  • Prothrombin / therapeutic use

Substances

  • Autoantibodies
  • Cryoprotective Agents
  • Cyclophosphamide
  • Prothrombin
  • Factor VIII
  • Factor IX